McNally; Elizabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for McNally; Elizabeth.The latest application filed is for "antisense polynucleotides to induce exon skipping and method of treating dystrophies".

Company Profile

13.6.23

McNally; Elizabeth - Oak Park IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20220251559 - McNally; Elizabeth	2022-08-11
Compositions And Methods For Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping App 20220119820 - McNally; Elizabeth ; et al.	2022-04-21
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20220089717 - McNally; Elizabeth ; et al.	2022-03-24
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20210403910 - McNally; Elizabeth	2021-12-30
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20210238274 - McNally; Elizabeth ; et al.	2021-08-05
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20210147845 - McNally; Elizabeth	2021-05-20
Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping App 20210032631 - McNally; Elizabeth ; et al.	2021-02-04
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20200385457 - McNally; Elizabeth ; et al.	2020-12-10
Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping Grant 10,801,029 - McNally , et al. October 13, 2	2020-10-13
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20200291403 - McNally; Elizabeth	2020-09-17
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20200123247 - McNally; Elizabeth ; et al.	2020-04-23
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20200040340 - McNally; Elizabeth	2020-02-06
Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4) App 20190256589 - McNally; Elizabeth ; et al.	2019-08-22
Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping App 20190249180 - McNally; Elizabeth ; et al.	2019-08-15
Antisense Polynucleotides To Induce Exon Skipping And Method Of Treating Dystrophies App 20190194659 - McNally; Elizabeth	2019-06-27
Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping Grant 10,273,483 - McNally , et al.	2019-04-30
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20190002557 - McNally; Elizabeth ; et al.	2019-01-03
Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies App 20180327743 - McNally; Elizabeth	2018-11-15
Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4) App 20180134785 - McNally; Elizabeth ; et al.	2018-05-17
Compositions And Methods For Correcting Limb Girdle Muscular Dystrophy Type 2c Using Exon Skipping App 20180080030 - McNally; Elizabeth ; et al.	2018-03-22
Antisense Polynucleotides To Induce Exon Skipping And Methods Of Treating Dystrophies App 20180037889 - McNally; Elizabeth	2018-02-08
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4) Grant 9,873,739 - McNally , et al. January 23, 2	2018-01-23
Antisense polynucleotides to induce exon skipping and methods of treating dystrophies Grant 9,777,271 - McNally October 3, 2	2017-10-03
Antisense Polynucleotides To Induce Exon Skipping And Methods Of Treating Dystrophies App 20160369277 - McNally; Elizabeth	2016-12-22
Antisense polynucleotides to induce exon skipping and methods of treating dystrophies Grant 9,499,817 - McNally November 22, 2	2016-11-22
Antisense Polynucleotides to Induce Exon Skipping and Methods of Treating Dystrophies App 20150225718 - McNally; Elizabeth	2015-08-13
Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (ltbp4) App 20140037637 - McNally; Elizabeth ; et al.	2014-02-06

Company Registrations

NCAGE Code	5KUB8	MCNALLY ELIZABETH!DBA SOLAR WINDOW TREATMENTS
CAGE Code	5KUB8	MCNALLY, ELIZABETH SOLAR WINDOW TREATMENTS
DUNS	831244889	MCNALLY, ELIZABETH

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.